These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25444632)

  • 21. Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate.
    Tukenmez Tigen E; Tandogdu Z; Ergonul O; Altinkanat G; Gunaydin B; Ozgen M; Sariguzel N; Erturk Sengel B; Odabasi Z; Cek M; Tokuc R; Turkeri L; Mulazimoglu L; Korten V
    Urology; 2014 Nov; 84(5):1008-15. PubMed ID: 25239255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial prophylaxis protocol based on rectal swab culture before prostate biopsy to prevent infectious complications: a prospective randomized comparative study.
    Bouzouita A; Rehaiem A; Saadi A; Zaghbib S; Chakroun M; Ayed H; Ferjani A; Derouiche A; Boubaker IB; Slama MRB
    Int Urol Nephrol; 2024 Aug; 56(8):2495-2502. PubMed ID: 38448785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
    Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
    J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine Ertapenem Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy does Not Select for Carbapenem Resistant Organisms: A Prospective Cohort Study.
    Bloomfield MG; Page MJ; McLachlan AG; Studd RC; Blackmore TK
    J Urol; 2017 Aug; 198(2):362-368. PubMed ID: 28288838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence and significance of fluoroquinolone-resistant and ESBL-producing
    Labi AK; Obeng-Nkrumah N; Dayie NTKD; Addo BM; Osei MM; Fenny A; Egyir B; Mensah JE
    JAC Antimicrob Resist; 2022 Dec; 4(6):dlac113. PubMed ID: 36349243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy.
    Sieczkowski M; Gibas A; Bronk M; Matuszewski M
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1815-21. PubMed ID: 26048634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis.
    Roberts MJ; Williamson DA; Hadway P; Doi SA; Gardiner RA; Paterson DL
    Int J Antimicrob Agents; 2014 Apr; 43(4):301-9. PubMed ID: 24630305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
    Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
    J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
    Cheung C; Patel HD; Landis P; Carter HB; Han M
    Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.
    Knaapila J; Gunell M; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Hakanen AJ; Boström PJ
    Eur Urol Focus; 2019 May; 5(3):443-448. PubMed ID: 29275146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectal Swabs for Detecting Multidrug Resistant Bacteria Prior to Transrectal Prostate Fusion Biopsy: A Prospective Evaluation of Risk Factor Screening and Microbiologic Findings.
    Würnschimmel C; Busto Martin L; Leyh-Bannurah SR; Oh-Hohenhorst SJ; Kachanov M; Maurer T; Knipper S; Graefen M; Budäus L
    Urology; 2020 Feb; 136():127-132. PubMed ID: 31705945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
    Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
    PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of antibiotic resistance in fecal flora before transrectal ultrasound-guided prostate biopsy and the clinical impact of targeted antibiotic prophylaxis.
    Ozgur A; Asif Y; Gokhan A; Berrin T; Cenk G; Bulent E; Onur D; Meftun C; Haluk V; Hulya C; Turhan C
    Arch Esp Urol; 2017 Dec; 70(10):852-858. PubMed ID: 29205165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
    Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of faecal ESBL carriers undergoing TRUS-guided prostate biopsy (TRUSPB): role of screening prior to TRUSPB.
    Bhatt NR; Murphy CA; Wall N; McEvoy E; Flynn RJ; Thomas AZ; Manecksha RP; Murphy PG; Smyth LG
    Ir J Med Sci; 2020 Aug; 189(3):817-823. PubMed ID: 31873877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy.
    Liss MA; Peterson EM; Johnston B; Osann K; Johnson JR
    Urology; 2013 Mar; 81(3):548-55. PubMed ID: 23333000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.